SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-324954
Filing Date
2018-11-13
Accepted
2018-11-13 08:49:31
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d621397d10q.htm 10-Q 808110
2 EX-31.1 d621397dex311.htm EX-31.1 6810
3 EX-31.2 d621397dex312.htm EX-31.2 6905
4 EX-32.1 d621397dex321.htm EX-32.1 3521
5 EX-32.2 d621397dex322.htm EX-32.2 3553
  Complete submission text file 0001193125-18-324954.txt   3711260

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT umrx-20180930.xml EX-101.INS 583498
7 XBRL TAXONOMY EXTENSION SCHEMA umrx-20180930.xsd EX-101.SCH 40608
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE umrx-20180930_cal.xml EX-101.CAL 57717
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE umrx-20180930_def.xml EX-101.DEF 139537
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE umrx-20180930_lab.xml EX-101.LAB 344936
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE umrx-20180930_pre.xml EX-101.PRE 247803
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 181175438
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1